OXIDATION POLYMORPHISM HAS CLINICAL RELEVANCE
- 28 July 1984
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 324 (8396) , 227
- https://doi.org/10.1016/s0140-6736(84)90513-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Polymorphic hydroxylation of perhexiline maleate in man.Journal of Medical Genetics, 1984
- PROTECTING POOR METABOLISERS, A GROUP AT HIGH RISK OF ADVERSE DRUG REACTIONSThe Lancet, 1983
- Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.British Journal of Clinical Pharmacology, 1982
- Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.BMJ, 1982
- PHENFORMIN-INDUCED LACTICACIDOSIS ASSOCIATED WITH IMPAIRED DEBRISOQUINE HYDROXYLATIONThe Lancet, 1981
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- Pharmacokinetics of perhexiline maleate in anginal patients with and without peripheral neuropathyEuropean Journal of Clinical Pharmacology, 1978
- Sparteine sulfate in laborAmerican Journal of Obstetrics and Gynecology, 1964